Articles |
From the Institutes of Clinical Medicine (I.T.), Community Medicine (K.H.B.), and Medical Biology (O.C.I.), University of Tromsø; the Department of Internal Medicine, Tromsø University Hospital (A.N., T.J.); and the Department of Clinical Chemistry, Aker Hospital, Oslo (K.I.B.), Norway.
Abstract Impaired fibrinolysis due to elevated levels of plasma plasminogen activator inhibitor type 1 (PAI-1) is a risk factor for thromboembolic disease. Hypertension, obesity, derangements in lipid and glucose homeostasis, and elevated levels of PAI-1 are features of the insulin resistance syndrome. The interrelationships between PAI-1 and the metabolic disturbances seen in this condition are unsettled. We investigated the associations between PAI-1 activity and components of the insulin resistance syndrome in 53 men and 31 women with untreated hypertension. In men, PAI-1 activity correlated significantly with plasma glucose (r=.41, P=.002), insulin sensitivity (r=-.35, P=.01), and insulin-induced suppression of nonesterified fatty acid (NEFA) (r=-.43, P=.007). Plasma glucose and NEFA suppression were independently associated with PAI-1 activity in a multivariate analysis. In women, PAI-1 activity correlated with body mass index (r=.62, P=.0005), waist-to-hip ratio (r=.75, P=.0001), plasma glucose (r=.50, P=.007), insulin (r=.49, P=.009), proinsulin (r=.57, P=.002), C-peptide (r=.60, P=.0009), insulin sensitivity (r=-.74, P=.0001), NEFA suppression (r=-.64, P=.003), and triglycerides (r=.58, P=.001). In multivariate analyses, insulin sensitivity and NEFA suppression were independently associated with PAI-1 if waist-to-hip ratio was not included in the model. After introduction of waist-to-hip ratio into the model, waist-to-hip ratio was the only independent predictor of PAI-1 activity. We conclude that in women, waist-to-hip ratio, body mass index, and insulin-induced NEFA suppression are determinants for PAI-1 activity. In men, insulin-induced NEFA suppression and plasma glucose are independently associated with PAI-1 activity.
Key Words: hypertension plasminogen activator inhibitor-1 insulin action waist-to-hip ratio
This article has been cited by other articles:
![]() |
J. M. Bard, M. A. Charles, I. Juhan-Vague, P. Vague, P. Andre, M. Safar, J. C. Fruchart, E. Eschwege, and o. b. o. t. BIGPRO Study Group Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity : The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 Study Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. M. Vrijkotte, L. J. P. van Doornen, and E. J. C. de Geus Work Stress and Metabolic and Hemostatic Risk Factors Psychosom Med, November 1, 1999; 61(6): 796 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Abbasi, T. McLaughlin, C. Lamendola, I. Lipinska, G. Tofler, and G. M. Reaven Comparison of Plasminogen Activator Inhibitor-1 Concentration in Insulin-Resistant Versus Insulin-Sensitive Healthy Women Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2818 - 2821. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Giltay, J. M. H. Elbers, L. J. G. Gooren, J. J. Emeis, T. Kooistra, H. Asscheman, and C. D. A. Stehouwer Visceral Fat Accumulation Is an Important Determinant of PAI-1 Levels in Young, Nonobese Men and Women : Modulation by Cross-Sex Hormone Administration Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1716 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Byberg, A. Siegbahn, L. Berglund, P. McKeigue, R. Reneland, and H. Lithell Plasminogen Activator Inhibitor-1 Activity Is Independently Related to Both Insulin Sensitivity and Serum Triglycerides in 70-Year-Old Men Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 258 - 264. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |